Cara Therapeutics, Inc. (CARA) Posts Mixed Q4 Results
Cara Therapeutics, Inc. (NASDAQ: CARA) reported Q4 EPS of ($0.49) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
